http://jcps.bjmu.edu.cn

中国药学(英文版) ›› 2014, Vol. 23 ›› Issue (10): 731-738.DOI: 10.5246/jcps.2014.10.093

• 【研究论文】 • 上一篇    

SNP新颖方法和个体化用药方案的研究进展

彭锐, 张洪*, 张英   

  1. 武汉大学人民医院 药学部
  • 收稿日期:2014-03-12 修回日期:2014-05-14 出版日期:2014-10-31 发布日期:2014-05-31
  • 通讯作者: Tel.: 86-27-88041911-88382
  • 基金资助:
    The Influence of Artesunate on β-catenin Signaling Pathway of Hetatic Atellate Cells (Grant No. 2011CDB491).

Recent advance in SNP identifying methods and individualized medication

Rui Peng, Hong Zhang*, Ying Zhang   

  1. Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, China
  • Received:2014-03-12 Revised:2014-05-14 Online:2014-10-31 Published:2014-05-31
  • Contact: Tel.: 86-27-88041911-88382
  • Supported by:
    The Influence of Artesunate on β-catenin Signaling Pathway of Hetatic Atellate Cells (Grant No. 2011CDB491).

摘要:

编码多种药物代谢酶和转运体基因多态性引起个体间药物代谢差异, 将影响药物有效性和药物副作用的发生。单核苷酸多态性涉及到所有遗传变异的类型, 正确地SNP基因分型方法能帮助检测遗传多态性、遗传紊乱、病原体耐药。个体化用药打破了传统给药的方式, 以个体特征为依据进行个体间用药。因此, SNP分型方法成为识别疾病敏感性和药物反应之间生物联系的关键因素。精确的基因分型方法对疾病的诊断和预后起着重要的作用。目前为止, 常用测序、变性高效液相色谱 (DHPLC)、单链构象多态性分析、变性梯度凝胶电泳等进行基因分型。但是, 他们的适用范围得到限制, 由于本身纯在的缺陷。本文总结了基因多态性检测的几种新型方法及比较了几种个体化用药方案的优缺点。

关键词: 单核苷酸多态性, 基因分型, 药物代谢酶, 转运体, 药物基因组学

Abstract:

Polymorphisms associated with genes coding for a variety of drug-metabolizing enzymes (DMEs) and associated transport proteins can influence the drug metabolism rate of individuals, potentially affecting the efficacy of drug and the occurrence of adverse reactions. Single nucleotide polymorphisms (SNPs) are prevalent in all types of genetic variations. Reliable SNP genotypingprovides excellent markers for detecting genetic polymorphisms, genetic disorders, and resistance of pathogen to drug, which are needed for the genetic diagnosis of disease and subtle genetic factors. With a large number of SNP genotyping studies being conducted, a lot of novel SNP identifying methods have been developed. Several SNP genotyping methods and techniques have been introduced for clinical test. These include TaqMan® drug metabolism genotyping assays, pH-sensing semiconductor system, high-resolution melting curve analysis (HRM) of polymerase chain reaction (PCR) amplicons, novel multiplexed electrochemical biosensor with non-fouling surface, DNA hybridization detection using less than 10-nm gap silicon nanogap structure, tetra-primer ARMS-PCR method, acoustic detection of DNA conformation in genetic assays combined with PCR, microbeads-mass spectrometry (MEMS)-based approach, and liquid chromatography-electrospray ionization mass spectrometry. Personalized medicine has changed the conventional ways of using drugs according to experiences. It focuses on making the individualized pattern for each individual based on their own characteristics. Lots of researchers are using the analysis of clinical samples to explain the relationship between the drug adverse reactions and genetic polymorphisms. But it takes a long time from collecting the blood samples for DNA extraction and genotyping to getting results on the side effect of drug through clinical study. Therefore, it is desirable to develop improved in vitro methods to study the drug metabolizing-enzymes and transport protein genetic polymorphisms.

Key words: Single nucleotide polymorphism, Genotyping, Drug-metabolizing enzymes, Transporters, Pharmacogenomics

中图分类号: 

Supporting: